Effects of phenylpropanolamine on withdrawal symptoms.

Abstract

A prior report (Klesges et al. 1990) suggested that phenylpropanolamine (PPA) was successful in reducing the smoking withdrawal symptom of weight gain in a sample of women. The current investigation evaluates whether the effects of phenylpropanolamine (PPA; up to 10/day PPA gums) on withdrawal symptoms associated with smoking cessation are specific to weight and weight-related symptoms or whether PPA alleviates withdrawal in general. One hundred and seven adult smokers (56 men, 51 women) were randomly assigned, in this double-blind trial, to chew either 8.33 mg phenylpropanolamine gum or a placebo gum. Subjects were then aided to quit smoking for 4 weeks. PPA did not enhance cessation rates. Results from the 47 subjects who successfully quit smoking indicated that postcessation weight gain and ratings of hunger were significantly reduced in both men and women for those assigned to the PPA group relative to the placebo group. Overall, no effects of PPA relative to placebo were observed for other smoking-related withdrawal symptoms. Thus, although PPA appears to reduce weight gain and alleviate weight-related symptoms, no effects on other withdrawal symptoms were observed. Future research directions are suggested.

• Authors: R C Klesges, L M Klesges, M DeBon, M L Shelton, T R Isbell, M L Klem
• Journal: Psychopharmacology (Psychopharmacology (Berl)) Vol. 119 Issue 1 Pg. 85-91 (May 1995) ISSN: 0033-3158 [Print] Germany
• PMID: 7675954 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Phenylpropanolamine

Topics

• Adult
• Blood Pressure (drug effects)
• Body Weight (drug effects)
• Female
• Humans
• Male
• Phenylpropanolamine (pharmacology)
• Smoking Cessation
• Substance Withdrawal Syndrome